News

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research ...
Me filed for bankruptcy in March, seeking to sell its business at auction after a decline in consumer demand and a 2023 data ...
The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...
Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.
Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.
PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...
The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.